CLINICAL ROLE -
August 28th 2025
An immunomodulatory nanoparticle called Agg-CLNP has been shown to effectively prevent disease onset for rheumatoid arthritis (RA).
Biosimilars can be a more affordable and accessible treatment option for patients with rheumatoid arthritis (RA) and psoriatic arthritis (PsA).
August 25th 2025
A systematic review and meta-analysis revealed key insights into lipid parameters in patients with systemic sclerosis.
August 21st 2025
New research confirms that switching from tocilizumab to its biosimilar, Avtozma, maintains efficacy and safety in patients with rheumatoid arthritis (RA).
July 29th 2025
The supplements were also linked to improvements in pain and disease activity markers.
Phase 1 Clinical Trial Launched for Orencia Biosimilar
Orencia is a fusion protein and the only CTLA-4lg approved in the United States for the treatment of rheumatoid arthritis.
Read More
Rheumatoid Arthritis Drug on Hold After FDA Rejection
The FDA discovered deficiencies in a Sanofi manufacturing facility for the rheumatoid arthritis drug sarilumab.
FDA Rejects Rheumatoid Arthritis Drug
Trending News Today: Many Hospitals Fail to Report Patient Deaths from Medical Devices
Top news of the day from across the health care landscape.
Remicade Biosimilar Set for US Launch Next Month
Inflectra is the first biosimilar monoclonal antibody approved by the FDA.
Trending News Today: Biosimilar Savings Lag Behind Expectations
Common Rheumatoid Arthritis Drug Effective in Treating Rare Eye Disease
Adalimumab also found to be effective in treating non-infectious uveitis.
Baricitinib for Rheumatoid Arthritis More Effective Than Methotrexate
Baricitinib monotherapy or in combination with methotrexate shows superiority treating rheumatoid arthritis.
JAK Inhibitor Shows Superiority in Active Rheumatoid Arthritis
Investigational drug used alone or in combination demonstrated superiority to methotrexate in patients with active rheumatoid arthritis.
Almost Half of Rheumatoid Arthritis Patients Discontinued Xeljanz Within a Year
Adherence programs needed to boost Xeljanz utilization for rheumatoid arthritis.
Humira Biosimilar Approved, But Not Interchangeable
Amgen’s biosimilar Amjevita approved for variety of anti-inflammatory diseases, however, ongoing litigation may prevent it from hitting the market.
Express Scripts Creates Outcomes-Based Payment Model
Refunds will be offered to plan sponsors if a patient discontinues a preferred anti-inflammatory drug within 90 days.
Enbrel Biosimilar Gains FDA Approval
Erelzi, an etanercept biosimilar, was approved for rheumatoid arthritis, plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and polyarticular juvenile idiopathic arthritis.
FDA Approves Biosimilar for Enbrel
Sandoz has gained FDA-approval for Erelzi, an etanercept biosimilar.
Link Found Between Rheumatoid Arthritis Drug and Flesh-Eating Infection
Patients taking medication that inhibits IL-1beta are 300 times more likely to develop a flesh-eating infection.
Trending News Today: Judge Rules Remicade Patent is Invalid
Trending News Today: Harnessing Technology to Fight Cancer
AbbVie Employs Delay Tactics for Humira Biosimilar
AbbVie alleges that Amgen is infringing on 61 patents with their biosimilar.
Anti-Interferon Autoantibodies Could Protect Against Diabetes
A small proportion of patients with autoimmune syndrome have diabetes.
Inflammatory Biosimilar Comparable to Branded Biologic
Biosimilar to rheumatoid arthritis and inflammatory bowel disease drug shows similar efficacy to brand name drug.
Trending News Today: Improvements in Veterans Health Care Delivery
Top news from across the health care landscape.
Gut Bacteria May Influence Rheumatoid Arthritis Treatment
Intestinal microbiota may help predict rheumatoid arthritis symptom severity and frequency.
Myeloma Could Potentially Be Caused by a Benign Condition
Approximately 1 in 100 patients with MGUS develop myeloma.
Nerve Stimulation Reduces Rheumatoid Arthritis Symptoms
Vagus nerve stimulation may prove an effective RA treatment strategy.
Biologic Autoinjector for Rheumatoid Arthritis Launches
Orencia ClickJect Autoinjector has an ergonomic design that may be beneficial for patients.
Bristol-Myers Squibb Launches Biologic Autoinjector for Rheumatoid Arthritis
What's So Special About Specialty Pharmacy
Is the cost of specialty drugs worth the price in small patient populations?
The Impact of Smoking and Obesity on Rheumatoid Arthritis Treatment
Body mass index and smoking could have significant impact on RA remission.
Autoimmune Diseases May Limit Lung Cancer Patient Eligibility for Immunotherapy
Immunotherapy for lung cancer patients may cause other conditions to become worse.